home / stock / bcab / bcab news


BCAB News and Press, BioAtla Inc. From 08/13/21

Stock Information

Company Name: BioAtla Inc.
Stock Symbol: BCAB
Market: NASDAQ
Website: bioatla.com

Menu

BCAB BCAB Quote BCAB Short BCAB News BCAB Articles BCAB Message Board
Get BCAB Alerts

News, Short Squeeze, Breakout and More Instantly...

BCAB - BioAtla Announces Second Quarter 2021 Financial Results And Provides Clinical Update

BioAtla Announces Second Quarter 2021 Financial Results And Provides Clinical Update $207.6 million cash balance expected to provide funding for operations into 2023 Continue to advance potentially registration enabling Phase 2 studies for mecbotamab vedotin (BA3011) and ozu...

BCAB - Tracking Baker Brothers Portfolio - Q1 2021 Update

Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...

BCAB - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead The big event next week could be the two-day FOMC meeting that will conclude with a policy statement and Jerome Powell p...

BCAB - BioAtla reports Q1 results

BioAtla (BCAB): Q1 net loss was $18.7M vs. a loss of $1.6M in last year's quarter.Cash and cash equivalents as of March 31, 2021 were $221.2 million.Press Release For further details see: BioAtla reports Q1 results

BCAB - BioAtla Announces First Quarter 2021 Financial Results And Provides Business Update

BioAtla Announces First Quarter 2021 Financial Results And Provides Business Update - Initiated potentially registration-enabling Phase 2 studies for our CAB-AXL-ADC in refractory sarcoma patients and NSCLC patients refractory to EGFR or PD-1/L1 inhibitors - Initiated potent...

BCAB - BioAtla misses on revenue

BioAtla (BCAB): FY net loss of $35.85MRevenue of $0.43M (-91.7% Y/Y) misses by $1.18M.Shares -0.67%.Press Release For further details see: BioAtla misses on revenue

BCAB - BioAtla: Intriguing Science, New IPO, A Name To Watch

BioAtla is developing selectively-targeting antibodies based on very interesting science. However, it is a new IPO, and current prices and cash reserves are not conducive to investment. This is one to add to your watchlist. For further details see: BioAtla: Intriguing Sc...

BCAB - Seeking Alpha Catalyst Watch

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

Previous 10 Next 10